Managing Editor
@ShahidNShah
@ShahidNShah
Oxford Cancer Biomarkers and Mira Precision Health Partnership
Oxford Cancer Biomarkers and Mira Precision Health Partner to Advance ToxNav® Cancer Test in the United States.
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s proprietary ToxNav® test in the United States, a revolutionary precision oncology tool designed to identify patients at high risk of severe toxicity from common chemotherapy treatments.
– Mira Precision Health, headquartered at the Mason 5155 BioHub in Mason, Ohio, is dedicated to advancing precision medicine by delivering innovative solutions that empower clinics, health systems, and independent providers. Together, OCB and Mira Precision Health will work to establish
Read on hitconsultant.net
Continue reading at hitconsultant.net
Make faster decisions with community advice
- How to Choose the Right QR Code Service Provider for Your Healthcare Organization
- Choosing the Right Particle Size Analyzer: Beyond the Price Tag
- $1.5B Processed via Athena Billing Last Year: How Top Providers Are Maximizing ROI
- Why Choose House of Zen as Your Woodland Hills Recovery Center?
- AI-powered EHR helps optimize clinical and administrative processes
Next Article
-
How to Choose the Right QR Code Service Provider for Your Healthcare Organization
In the age of digital transformation, the healthcare sector is under growing pressure to provide more efficient, secure, and patient-centric services. One tool gaining momentum across hospitals, …
Posted Jun 1, 2025 Healthcare Innovation Healthcare
